ABIGO Medical AB – celebrating its 25th anniversary, 25 years of success!
This was recognized this year on May 9 to 10 with both a party as a two-day internal arrangement where all the company’s employees participated. Also deliberate plans and strategies for the company’s future expansion was presented.
”Research and development, innovative & unique products, globalization, growth and sustainability” are the key words for the company.
ABIGO is a complete pharmaceutical company with integrated R&D, manufacturing and marketing. The headquarters are located in Gothenburg, where we also have our dedicated research laboratory. We have our own manufacturing facility in Askersund. ABIGO has over 85 employees and an annual revenue of approximately SEK 200 million.
ABIGO is focused internationally with an extensive international distribution network. In Sweden, Norway and Denmark, ABIGO manages its own sales organization while through a global network of distributors our products are sold in over 70 countries worldwide. The international growth of ABIGO has taken place at a significant rate and a rate that will continue to improve.
ABIGO operates two business areas; pharmaceuticals, and medical devices. The pharmaceutical division comprises a broad range of both prescription – and OTC products while the medical devices division consists of an advanced wound care product line and ENT (ear-nose-throat) products.
ABIGO is a family owned Swedish pharmaceutical company, founded 1989 by the two Brothers Jan G. Smith and Leif Smith and still managed and wholly owned by them. The company has the highest credit rating, AAA. This means good economy, quick decisions but also a positive tone. It should be stimulating to work with ABIGO, good spirit in the company is a key word for us.
AWMA 2014 – Best Poster Award
Congratulations to Carin Ottosson and Ann-Mari Fagerdahl for winning the ‘Best Poster Award’ at the Australian Wound Management Association (AWMA) conference that was recently held on the Gold Coast, Australia. The poster was titled “Bacteria and fungi binding mesh used as a NPWT wound filler for managing Pseudomonas aeruginosa”
Their prize was received in front of 900 applauding AWMA delegates.
Otovent in an updated packaging
Otovent is now released in its new package! We are happy to be able to introduce this package on all markets in the world.
For more information also see www.otovent.se
NPWT Wound Filler
At EWMA in Copenhagen, ABIGO launched Sorbact® NPWT Wound Filler. Product development truly driven by the market.
When a lot of cases was coming in from all corners of the world where Sorbact® was being used as a wound filler in NPWT treatment, ABIGO realized that we needed to make a product available.
Cooperating with some of the world leading experts in the field of NPWT, ABIGO this year at EWMA released Sorbact® NPWT Wound Filler for the European market.
The main advantages against foam fillers is that Sorbact® has limited tissue ingrowth for easy and painless removal. In addition it is easy to line and adapt to complex wound cavities. The main advantage compared to gauze is the great liquid handling capacity of Sorbact®.
Please download the Sorbact® NPWT folder to learn more. You find it under products.
Ref no: 98425
17 x 28 cm (7 x 11 in)
Ref no: 98410
10 x 100 cm (4 x 39 in)
Sponsor for EWMA
Meaningful sponsorship for ABIGO
Since the beginning of the year 2013 is ABIGO Medical B-sponsor for EWMA – The European Wound Management Association.
By being an industrial partner ABIGO Medical can contribute with knowledge in the area of wound healing treatment and also have a dialogue with all companies who have the same interest in management of wounds connected to EWMA.
The European Wound Management Association was founded in 1991. It works with linking wound management associations across Europe and bringing together individuals and organisations interested in wound treatment. By also being an educational resorce, organising conferences, contributing to international projects related to wounds and provide a wide range of information, ABIGO feels that this is a meaningful sponsorship for the company.
ABIGO Medical is proud to be a part of EWMA and be a part of the EWMA wound healing world with all the other A and -B corproate sponsors.
– It´s a great feeling and a step in the right direction. It also follows the ambition to be an internationally leading player in this area, says Anders Elliot, Export Manager at ABIGO Medical´s headoffice in Gothenburg, Sweden.
ABIGO in Norway
ABIGO Medical AS in Norway participated on a congress for the Norwegian organization of wound therapy in February with 350 delegates, both doctors and nurses specialized in wound therapy.
The exhibition was well visited with a lot of interested customers. Many of them with experience of Sorbact® and also many that wanted to share their success stories with us regarding their use of Sorbact® in treatment of complicated wounds & hard to heal wounds.